Interleukin 20 receptor A expression in colorectal cancer and its clinical significance

Interleukin 20 receptor A expression in colorectal cancer and its clinical significance

Background Interleukin 20 receptor A (IL20RA) has been shown to play a role in the establishment and progression of multiple tumors. However, the expression of this protein in colorectal cancer (CRC) and its correlation with the clinicopathological parameters of CRC have remained unclear. Methods A...

Full description

Bibliographic Details
Main Authors:	Rui Liu, Honghao Yin, Xin Sun, Songyi Liu, Ang Wang, Ying Wu, Yuan Yuan, Yuehua Gong, Chengzhong Xing
Format:	Article
Language:	English
Published:	PeerJ Inc. 2021-11-01
Series:	PeerJ
Subjects:	Colorectal cancer IL20RA IHC Differentially expressed genes Regulatory network
Online Access:	https://peerj.com/articles/12467.pdf

Similar Items

Super-Enhancer Induced IL-20RA Promotes Proliferation/Metastasis and Immune Evasion in Colorectal Cancer
by: Dingye Yu, et al.
Published: (2021-07-01)

Expression of MHC class I polypeptide-related sequence A (MICA) in colorectal cancer
by: Ingrid Espinoza, et al.
Published: (2021-10-01)

A systematic CRISPR screen reveals an IL-20/IL20RA-mediated immune crosstalk to prevent the ovarian cancer metastasis
by: Jia Li, et al.
Published: (2021-06-01)

The Involvement of TRIB3 and FABP1 and Their Potential Functions in the Dynamic Process of Gastric Cancer
by: Songyi Liu, et al.
Published: (2021-12-01)

The Significant Impacts of Interleukin-8 Genotypes on the Risk of Colorectal Cancer in Taiwan
by: Chia-Wen Tsai, et al.
Published: (2023-10-01)

Aberrantly methylated-differentially expressed genes and pathways in colorectal cancer
by: Jingwei Liu, et al.
Published: (2017-08-01)

HER2 (ERBB2) alterations in colorectal cancers
by: Nika Tavberidze, et al.
Published: (2022-06-01)

High expression of interleukine-1 receptor antagonist in rheumatoid arthritis: Association with IL1RN*2/2 genotype
by: S. Ramírez-Pérez, et al.
Published: (2017-11-01)

XPF expression and its relationship with the risk and prognosis of colorectal cancer
by: Huixin Hu, et al.
Published: (2021-01-01)

Interleukin-27 and interleukin-35 in de novo acute myeloid leukemia: expression and significance as biological markers
by: Ahmed HA, et al.
Published: (2019-10-01)

Postoperative Serum Levels of Interleukin-6 are Affected by Age in Patients with Colorectal Cancer
by: Tzu-Chi Hsu, et al.
Published: (2017-06-01)

Minimally-invasive Sampling of Interleukin-1α and Interleukin-1 Receptor Antagonist from the Skin: A Systematic Review of In vivo Studies in Humans
by: Denise Falcone, et al.
Published: (2017-06-01)

Editorial: The IL-20 Cytokines and Related Family Members in Immunity and Diseases
by: Jan Hendrik Niess, et al.
Published: (2019-08-01)

Interleukin-20 is involved in dry eye disease and is a potential therapeutic target
by: Hsiao-Hsuan Wang, et al.
Published: (2022-06-01)

Molecular and pathogenetic aspects of tumor budding in colorectal cancer
by: Heather eDawson, et al.
Published: (2015-03-01)

Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling
by: Dan Wang, et al.
Published: (2019-08-01)

Identification of DEGs and transcription factors involved in H. pylori-associated inflammation and their relevance with gastric cancer
by: Honghao Yin, et al.
Published: (2020-06-01)

IL-36 s in the colorectal cancer: is interleukin 36 good or bad for the development of colorectal cancer?
by: Feier Chen, et al.
Published: (2020-02-01)

Interleukin‐33 as an early predictor of cetuximab treatment efficacy in patients with colorectal cancer
by: Xujun Zhang, et al.
Published: (2021-12-01)

Avaliação da expressão de interleucina 1 beta (IL-1β) e antagonista do receptor de interleucina 1 (IL-1Ra) em pacientes com hanseníase Evaluation of the expression of interleukin 1 beta(IL-1β) and interleukin 1 receptor antagonist (IL-1Ra) in leprosy patients
by: Rosane Dias Costa, et al.
Published: (2008-01-01)

Correlation between Frequency of P53 and P21 Proteins with Pathological Parameters in Colorectal Adenocarcinoma
by: M Jahantigh, et al.
Published: (2012-03-01)

Interleukin-1 receptor blockade in perinatal brain injury
by: Jason eRosenzweig, et al.
Published: (2014-10-01)

The Role of Interleukin-20 in Paclitaxel-Associated Peripheral Neuropathy in Non-Metastatic Breast Cancer Patients Receiving Chemotherapy
by: Kubilay Karaboyun, et al.
Published: (2023-11-01)

Impact of the Functional VNTR Variants of the Interleukin-1 Receptor Antagonist and Interleukin-4 Genes on Oral Squamous Cell Carcinoma
by: Özge Gümüşay, et al.
Published: (2019-05-01)

Differences in the Levels of Interleukin-1β (IL-1β) and Interleukin-1 Receptor Antagonist (IL-1ra) in Children with Status Epilepticus and Febrile Seizure
by: Fita Shofiyah, et al.
Published: (2017-09-01)

Unique characteristics of the tumor immune microenvironment in young patients with metastatic colorectal cancer
by: Brian D. Griffith, et al.
Published: (2023-12-01)

The roles of IL-19 and IL-20 in the inflammation of degenerative lumbar spondylolisthesis
by: Kuo-Yuan Huang, et al.
Published: (2018-09-01)

Interleukin-1 receptor antagonist (IL-1RA) and interleukin-4 (IL-4) variable number of tandem repeat polymorphisms in schizophrenia and bipolar disorder: an association study in Turkish population
by: Sacide Pehlivan, et al.
Published: (2022-08-01)

Interleukin-1 receptor antagonist gene polymorphism in patients with multidrug-resistant Acinetobacter baumannii-associated pneumonia
by: Min-Jer Hsu, et al.
Published: (2012-01-01)

IL15RA and SMAD3 Genetic Variants Predict Overall Survival in Metastatic Colorectal Cancer Patients Treated with FOLFIRI Therapy: A New Paradigm
by: Elena De Mattia, et al.
Published: (2021-04-01)

Interleukin 20 receptor subunit beta (IL20RB) predicts poor prognosis and regulates immune cell infiltration in clear cell renal cell carcinoma
by: Haoxun Zhang, et al.
Published: (2022-07-01)

HER2 overexpression is a putative diagnostic and prognostic biomarker for late-stage colorectal cancer in North African patients
by: Eman A. Abdul Razzaq, et al.
Published: (2021-01-01)

Intra‐articular interleukin‐1 receptor antagonist (IL1‐ra) microspheres for posttraumatic osteoarthritis: in vitro biological activity and in vivo disease modifying effect
by: Khaled A. Elsaid, et al.
Published: (2016-01-01)

The Interleukin-20 Cytokines in Intestinal Diseases
by: Jan Hendrik Niess, et al.
Published: (2018-06-01)

Comparison of PD‐L1 detection assays and corresponding significance in evaluation of diffuse large B‐cell lymphoma
by: Sixia Huang, et al.
Published: (2019-07-01)

Molecular Signatures of Human Regulatory T Cells in Colorectal Cancer and Polyps
by: Nor Adzimah Johdi, et al.
Published: (2017-05-01)

IL-13/IL-13RA2 signaling promotes colorectal cancer stem cell tumorigenesis by inducing ubiquitinated degradation of p53
by: Baoyu He, et al.
Published: (2024-01-01)

The IL-20RB receptor and the IL-20 signaling pathway in regulating host defense in oral mucosal candidiasis
by: John E. Beute, et al.
Published: (2022-09-01)

Imbalance Between Interleukin-1β and Interleukin-1 Receptor Antagonist in Epicardial Adipose Tissue Is Associated With Non ST-Segment Elevation Acute Coronary Syndrome
by: Valentina Parisi, et al.
Published: (2020-02-01)

Possible Role of Interleukin-6 in Rheumatoid Arthritis
by: Batool A. Al-Haidary
Published: (2007-07-01)